Literature DB >> 16333100

Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women.

James R Johnson1, Krista Owens, Abby Gajewski, Michael A Kuskowski.   

Abstract

Characteristics differentiating Escherichia coli strains that cause cystitis or pyelonephritis from fecal E. coli remain incompletely defined, particularly among adult women in the United States. Accordingly, phylogenetic group, O antigens, and virulence factors (VFs) were analyzed among 329 E. coli isolates from the mid-to-late 1990s from women in the United States with acute pyelonephritis (n = 170), cystitis (n = 83), or no infection (fecal; n = 76). Compared with fecal and cystitis isolates, pyelonephritis isolates exhibited a greater prevalence of phylogenetic group B2, most virulence-associated O antigens, and most VFs and had higher VF scores. In contrast, cystitis and fecal isolates differed minimally. By stepwise multivariable logistic regression, significant (P < or = 0.015) predictors of cystitis and/or pyelonephritis (versus fecal) included afa/dra (Dr-binding adhesins), ibeA (invasion of brain endothelium), iha (putative adhesin-siderophore), malX (pathogenicity island marker), the O75 antigen, papEF (P fimbriae), papG allele II (P adhesin variant), group B2, and sfa/foc (S and F1C fimbriae). However, virulence profiles overlapped considerably among source groups and varied greatly within each group. E. coli "clonal group A" (CGA) and the O2:K5/K7:H1 and O75:K+ clonal groups were significantly associated with cystitis and/or pyelonephritis. These findings identify potential vaccine targets, suggest that urovirulence is multiply determined, and confirm the urovirulence of specific E. coli clonal groups, including recently recognized CGA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333100      PMCID: PMC1317206          DOI: 10.1128/JCM.43.12.6064-6072.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC.

Authors:  T A Russo; J R Johnson
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

2.  Clonal origin, virulence factors, and virulence.

Authors:  J R Johnson; M Kuskowski
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

3.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

4.  Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection.

Authors:  James R Johnson; Flemming Scheutz; Peter Ulleryd; Michael A Kuskowski; Timothy T O'Bryan; Torsten Sandberg
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

Authors:  D A Talan; W E Stamm; T M Hooton; G J Moran; T Burke; A Iravani; J Reuning-Scherer; D A Church
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

6.  In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection.

Authors:  N W Gunther; V Lockatell; D E Johnson; H L Mobley
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Escherichia coli O18:K1:H7 isolates from patients with acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles.

Authors:  J R Johnson; P Delavari; T T O'Bryan
Journal:  J Infect Dis       Date:  2000-12-20       Impact factor: 5.226

8.  Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay.

Authors:  J R Johnson; A L Stell; F Scheutz; T T O'Bryan; T A Russo; U B Carlino; C Fasching; J Kavle; L Van Dijk; W Gaastra
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

9.  Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroN(E. coli), among Escherichia coli isolates from patients with urosepsis.

Authors:  J R Johnson; T A Russo; P I Tarr; U Carlino; S S Bilge; J C Vary; A L Stell
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

10.  Virulence factors and O groups of Escherichia coli isolates from patients with acute pyelonephritis, cystitis and asymptomatic bacteriuria.

Authors:  M Blanco; J E Blanco; M P Alonso; J Blanco
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

View more
  37 in total

1.  The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012).

Authors:  James R Johnson; Stephen Porter; Paul Thuras; Mariana Castanheira
Journal:  Open Forum Infect Dis       Date:  2017-05-02       Impact factor: 3.835

2.  O serogroups, phylogeny, and virulence factors of cervicovaginal and rectal Escherichia coli isolates.

Authors:  D W Hilbert; T E Paulish; E Mordechai; M E Adelson; J P Trama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-27       Impact factor: 3.267

3.  Virulence potential of Escherichia coli strains causing asymptomatic bacteriuria during pregnancy.

Authors:  Jean-Philippe Lavigne; Adeline Boutet-Dubois; Dorsaf Laouini; Christophe Combescure; Nicole Bouziges; Pierre Marès; Albert Sotto
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

4.  The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.

Authors:  Priscila Reina Siliano; Lillian Andrade Rocha; José Osmar Medina-Pestana; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

5.  Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009.

Authors:  James R Johnson; Stephen Porter; Paul Thuras; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

6.  Cyclomodulins in urosepsis strains of Escherichia coli.

Authors:  Damien Dubois; Julien Delmas; Anne Cady; Frédéric Robin; Adeline Sivignon; Eric Oswald; Richard Bonnet
Journal:  J Clin Microbiol       Date:  2010-04-07       Impact factor: 5.948

7.  Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae.

Authors:  Rachel R Spurbeck; Ann E Stapleton; James R Johnson; Seth T Walk; Thomas M Hooton; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

8.  Pathogenicity island markers, virulence determinants malX and usp, and the capacity of Escherichia coli to persist in infants' commensal microbiotas.

Authors:  Anna Ostblom; Ingegerd Adlerberth; Agnes E Wold; Forough L Nowrouzian
Journal:  Appl Environ Microbiol       Date:  2011-02-11       Impact factor: 4.792

9.  Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens.

Authors:  Timothy J Johnson; Yvonne Wannemuehler; Sara J Johnson; Adam L Stell; Curt Doetkott; James R Johnson; Kwang S Kim; Lodewijk Spanjaard; Lisa K Nolan
Journal:  Appl Environ Microbiol       Date:  2008-09-26       Impact factor: 4.792

10.  Genetic relatedness and virulence gene profiles of Escherichia coli strains isolated from septicaemic and uroseptic patients.

Authors:  N L Ramos; M L Saayman; T A Chapman; J R Tucker; H V Smith; J Faoagali; J C Chin; A Brauner; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.